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Abstract
Background: Previous studies have shown complications of pregnancy, often examined in 
aggregate, to be associated with autism spectrum disorder (ASD). Results for specific 
complications such as maternal diabetes and hypertension have not been uniformly consistent and 
should be investigated independently in relation to ASD in a large community-based sample.
Methods: The Study to Explore Early Development (SEED), a U.S. multisite case-control study, 
enrolled children born in 2003–2006 at 2–5 years of age. Children were classified into three 
groups based on confirmation of ASD (n=698), non-ASD developmental delay (DD; n= 887), or 
controls drawn from the general population (POP; n=979). Diagnoses of any diabetes or 
hypertensive disorder during pregnancy were identified from prenatal medical records and 
maternal self-report. Logistic regression models estimated adjusted odds ratios (aOR) and 
confidence intervals (CI) adjusting for maternal age, race/ethnicity, education, smoking during 
pregnancy, and study site. Models for hypertension were additionally adjusted for parity and 
plurality.
Results: Among 2,564 mothers, we identified 246 (9.6%) with any diabetes and 386 (15.1%) 
with any hypertension in pregnancy. After adjustment for covariates, any diabetes during 
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pregnancy was not associated with ASD (aOR=1.10 [95% CI 0.77, 1.56]), but any hypertension 
was associated with ASD (aOR=1.69 [95% CI 1.26, 2.26]). Results were similar for DD, and any 
diabetes (aOR=1.29 [95% CI 0.94 1.78]) or any hypertension (aOR=1.71 [95% CI 1.30, 2.25]).
Conclusions: Some pregnancy complications, such as hypertension, may play a role in autism 
etiology and can possibly serve as a prompt for more vigilant ASD screening efforts.
Lay Summary
We studied if common complications in pregnancy are associated with autism spectrum disorder 
(ASD) in a large sample of mothers and children. Our results show an association between 
conditions marked by high blood pressure and ASD, but no association with conditions marked by 
high blood sugar and ASD. Associations were similar for children who had a developmental 
disorder that was not ASD, suggesting that this relationship may not be specific to ASD.
INTRODUCTION
Autism spectrum disorder (ASD) is a heterogeneous group of neurodevelopmental disorders 
characterized by deficits in social interaction and communication, as well as restrictive and 
repetitive patterns of behaviors or interests [APA, 2013]. While the documented prevalence 
of ASD has steadily increased [Baio et al., 2018], the complex etiology of ASD remains 
largely unknown and suspected to involve both genetic and environmental factors 
[Hallmayer et al., 2011; Sandin et al., 2014]. Several studies implicate the prenatal period as 
a sensitive time window for the development of ASD [Willsey et al., 2013; Stoner et al., 
2014; Ben-Ari, 2015].
Pregnancy complications have been frequently reported in association with the development 
of ASD [Gardener et al., 2009]. Maternal diabetes and hypertension are the most common 
complications of pregnancy and have increased over recent decades in the United States due 
to trends in increasing maternal age and obesity [Wallis et al., 2008; Albrecht et al., 2010]. It 
is possible that both conditions affect fetal brain development through pathways involving 
altered nutrient delivery [Harding, 2001] and inflammation [Jonakait, 2007]. Some previous 
studies have shown positive associations between maternal diabetes and ASD [Leonard et 
al., 2006; Lyall et al., 2012; Gregory et al., 2013; Xiang et al., 2015; Connolly et al., 2016] 
and maternal hypertension and ASD [Mann et al., 2010; Langridge et al., 2013; Polo-
Kantola et al., 2014; Walker et al., 2015]; yet others did not strongly implicate these 
conditions [Juul-Dam et al., 2001; Hultman et al., 2002; Krakowiak et al., 2012; Li et al., 
2016]. Some inconsistencies may be attributable to variable study designs, the use of 
administrative data, and limited sample size. In this analysis, we use rich data from the 
Study to Explore Early Development [Schendel et al., 2012] to examine the association 
between maternal diabetes and hypertension and ASD.
METHODS
Study Population
The Study to Explore Early Development (SEED) is a U.S. multisite case-control study with 
multiple-source ascertainment of children with ASD, children with developmental delays 
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other than ASD (DD), and children sampled from the general population [POP; Schendel et 
al., 2012]. Children in the ASD and DD groups were ascertained through multiple agencies 
and clinical settings that evaluate or serve children with developmental challenges. This 
broad diagnostic net for ascertainment better captures ASD among both previously 
diagnosed and undiagnosed children [Schendel et al., 2012]. State birth records were 
randomly sampled to identify children from the general population (POP group) who were 
born in the same time period and catchment area.
Children eligible for SEED were required to have been born and currently reside in one of 
six multi-county catchment areas in California, Colorado, Georgia, Maryland, North 
Carolina, and Pennsylvania [Schendel et al., 2012]. Children also had to be between the ages 
of 30 and 68 months of age at the time of in-person assessment, born between September 1, 
2003 and August 31, 2006, and live with a knowledgeable caregiver who was at least 18 
years of age, spoke English (all sites) or Spanish (California and Colorado), and was able to 
provide legal consent. This analysis was restricted to participants who completed the 
developmental assessment, had a final outcome classification of ASD, DD, or POP, and had 
data available on pregnancy complications.
Data Collection
The SEED data collection protocol is detailed elsewhere [Schendel et al., 2012]. SEED 
collected data on family medical history, maternal reproductive health and pregnancy 
outcomes, and child development and behavioral characteristics through telephone 
interviews, self-administered forms, an in-person child developmental assessment, collection 
of biosamples, and abstraction of maternal and child medical records. Limited birth 
certificate data were also obtained for all enrolled participants; however, information on 
pregnancy complications was not abstracted from the birth certificate. Data collection was 
standardized across sites and subject to uniform standards for quality data checks.
Outcome Assessment
All children enrolled in the study were initially screened for autism symptoms using the 
Social Communication Questionnaire [SCQ; Rutter et al., 2003]. As part of the data 
collection protocol, children were administered developmental assessments in-person by a 
trained clinician and were given a more extensive assessment if they screened positive for 
possible ASD (SCQ score >11), were determined to have a previous ASD diagnosis, or were 
suspected to have ASD based on the study clinician’s direct observation. The more extensive 
assessment of the child included the Autism Diagnostic Observation Schedule [ADOS; 
Gotham et al., 2007]. Additionally, their caregivers completed the Autism Diagnostic 
Interview-Revised [ADI-R; Lord et al., 1994]. Final classification of ASD (yes or no) was 
based on the findings from these two developmental assessments [Wiggins et al., 2015]. 
Children who were suspected to have ASD but screened negative on the SCQ or did not 
meet ADOS and ADI-R criteria for ASD were classified as DD. Children with DD who had 
some ASD characteristics were excluded from this analysis. Children who screened negative 
on the SCQ and were sampled from birth records were classified as POP. More detail about 
the SEED outcome assessment is described elsewhere [Schendel et al., 2012; Wiggins et al., 
2015].
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Ascertainment of Maternal Hypertension and Diabetes
Multiple SEED instruments included information on any hypertension and diabetes during 
pregnancy: 1) prenatal care records; 2) telephone interview administered to the caregiver that 
included questions on her health during pregnancy; and 3) self-administered checklists of the 
mother’s medical history both before and during pregnancy, used specifically for diabetes. 
Overall, prenatal medical record data were available for 67.3% of our study sample, and 
maternal self-report data were available for 99.5%. Among the 1,711 participants who had 
both medical record and self-reported data available, we found substantial to high agreement 
for both maternal diabetes (κ=0.85 95% CI 0.80, 0.89) and maternal hypertension (κ=0.66 
95% CI 0.61, 0.71), based on Landis and Koch criteria [Landis & Koch, 1977]. Thus, the 
mother was classified as having the condition if it was reported in the prenatal medical 
record or by maternal self-report (either telephone interview or on self-checklist). 
Additionally, if the condition was reported by both medical record and self-report, the 
mother was further classified as having a ‘Confirmed’ condition (see below).
Maternal diabetes was further classified as gestational diabetes (GDM) or pre-existing 
diabetes (including Type 1 and Type 2 Diabetes Mellitus). These sub-classifications are 
mutually exclusive. In addition to reported diagnoses of GDM, results from oral glucose 
tolerance tests (OGTT) in the prenatal medical record were used to classify GDM. Clinical 
guidelines by Carpenter and Coustan requiring two elevated measurements in the OGTT 
were used [Coustan et al., 1989]. Four mothers were classified as having diabetes only by 
OGTT criteria. Mothers were classified as having ‘Confirmed’ diabetes if they met criteria 
on the OGTT or if the condition was reported by both medical record and self-report. If only 
one data source specified a diabetes type but the other confirmed a non-specified type of 
diabetes or use of antidiabetic medications (Insulin, Glyburide, or Metformin), then the 
mother was also classified as having ‘Confirmed’ diabetes through both sources. We defined 
‘No Diabetes’ as not having a diagnosis in the medical record and no maternal report of 
diabetes.
Additionally, using any data source, 386 mothers (15.1%) were classified as having any 
hypertensive disorder during pregnancy (maternal hypertension). Mothers in the 
hypertension group were classified as having pre-existing chronic hypertension, pregnancy 
induced hypertension (PIH), or a more severe hypertensive disorder of pregnancy, including 
preeclampsia, eclampsia or hemolysis, elevated liver enzymes, and low platelet count 
(HELLP) syndrome. Sub-classifications were not mutually exclusive as mothers may have 
pre-existing chronic hypertension and then go on to develop preeclampsia, eclampsia, or 
HELLP syndrome in pregnancy. In addition to reported diagnoses, serial blood pressure 
measurements from clinic and hospital visits were used to classify a woman as having a 
hypertensive disorder, depending on the timing of these measurements. Clinical guidelines 
requiring two separate elevated measurements (systolic blood pressure ≥140 mmHg or 
diastolic blood pressure ≥90 mmHg) were used to classify the mother as having pre-existing 
chronic hypertension (if <20 weeks gestational age), PIH (if >20 weeks gestational age), or 
preeclampsia (if ≥20 weeks gestational age and accompanied by use of Magnesium) 
[American College of et al., 2013]. Forty-one mothers were classified as having 
hypertension only by blood pressure measurement criteria. Mothers were classified as 
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having ‘Confirmed’ hypertension if they met the blood pressure measurement or reported a 
hypertensive disorder through both self-report and medical record. We defined ‘No 
Hypertension’ as not having a diagnosis for a hypertensive disorder in the medical record 
and no maternal report of a hypertensive disorder.
Covariates
We conducted a thorough literature search to identify covariates that may be potential 
confounders in the association of these maternal conditions with ASD or broader 
developmental delays. For each condition, a Directed Acyclic Graph was used to identify 
potential confounders in order to obtain the least biased estimates [Shrier & Platt, 2008]. 
Data from birth certificates, prenatal medical records, and caregiver phone interview were 
used to define covariates. Odds ratios and 95% confidence intervals were obtained for the 
effect of each covariate on both the maternal condition and the outcome.
Confounders included maternal age at conception (continuous variable), maternal race/
ethnicity (white non-Hispanic [referent] vs. other race/ethnicity), maternal education (high 
school degree or less vs. some college or more [referent]), maternal smoking during 
pregnancy (any vs. none [referent]), and study site (Georgia as referent). Hypertension and 
diabetes were more prevalent among non-Hispanic Black and Hispanic women, but neither 
group was of sufficient size to further refine racial categories. For hypertension models, 
parity (categorized as first birth [referent], second birth, third or more) and plurality 
(dichotomized as singleton [referent] vs. multiple) were included as additional confounders. 
For both maternal conditions, other potential confounders included having the other 
condition (diabetes or hypertension) and pre-pregnancy body mass index (BMI), categorized 
using World Health Organizations levels for low or normal BMI (referent; <25 kg/m2), 
overweight (≥ 25 – 30 kg/m2), and obese (≥ 30 kg/m2). However, because the exact onset of 
the maternal condition is unknown, it is possible that one maternal condition could affect or 
be affected by the occurrence of the other condition; therefore, we treated the other 
condition and BMI as potential confounders (added separately in the adjustment set), also as 
potential mediators (excluded from the adjustment set), and evaluated for statistical 
interaction. Preterm birth, defined as a gestational age <37 weeks, is also an important 
mediator in this association. We therefore evaluated if associations remained among infants 
born at term.
Statistical Analysis
We calculated distributions of maternal characteristics by child outcome and maternal 
condition. We evaluated differences in maternal characteristics across study groups using 
Chi-square tests based on alpha=0.05. Multivariable logistic regression models estimated 
odds ratios (OR) and 95% confidence intervals (CI) for the association between maternal 
conditions and either ASD (vs. POP) or DD (vs. POP), adjusting for all confounders. We 
further adjusted for pre-pregnancy BMI and presence of other condition in separate models. 
In unadjusted models, we used the Breslow-Day test for homogeneity of the odds ratio with 
an alpha level α=0.10 for interaction. In adjusted models, we obtained stratum-specific 
effect estimates by BMI category and preterm birth (<37 weeks gestation) for diabetes and 
Cordero et al. Page 5
Autism Res. Author manuscript; available in PMC 2020 June 01.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
hypertension in association with ASD and DD, and tested the assumption of a multiplicative 
model.
Analyses were replicated in separate samples including only those with a confirmed 
condition and also for sub-classifications of the condition. Effect estimates were also 
obtained for ASD with and without intellectual disability (ID) vs. POP, as previous studies 
have concluded that they may be etiologically distinct [Li et al., 2016]. A Mullen Early 
Learning Composite Standard Score of <70 was used to identify ASD children with ID 
[Mullen, 1995]. All analyses were conducted using SAS statistical software, version 9.3 
(SAS Institute Inc., Cary, NC).
RESULTS
This analysis comprises a sample of 2,564 mother-child pairs enrolled in SEED. The study 
sample included 698 children with ASD, 887 with a non-ASD DD, and 979 from the POP 
group. Compared to our analytic sample, the excluded subset (n=1,205) was less likely to be 
non-White and less likely to have attained a higher education (data not shown). Mothers of 
children with ASD and DD were less likely to be White, less educated, and more likely to 
smoke during pregnancy, have higher pre-pregnancy BMI, or deliver a multiple birth, 
compared with POP mothers (Table 1). They were also more likely to have a hypertensive 
disorder, compared with POP mothers.
There were 246 mothers (10%) with any report of diabetes during pregnancy; 65 (3%) were 
classified with pre-existing diabetes and 181 (7 %) with GDM (Table 1). Among mothers 
with any diabetes, 151 (61%) had confirmed diabetes (i.e. record in both medical record and 
self-report), 33 (13%) were classified by only maternal report and 14 (6%) by only prenatal 
medical record. Hypertensive disorders were present during pregnancy for 386 mothers 
(15%), with 89 (3%) classified with pre-existing chronic hypertension, 282 (11%) with PIH, 
and 164 (6 %) with more severe hypertensive disorders of pregnancy such as preeclampsia, 
eclampsia, and HELLP syndrome (Table 1). Among mothers with any hypertensive disorder 
during pregnancy, 195 (51%) conditions were confirmed, 78 (20%) were classified as having 
a hypertensive disorder only by maternal report and 64 (17%) only by prenatal medical 
record.
In unadjusted analyses, we did not observe an association between any diabetes and ASD 
(OR=1.24 [0.89, 1.75]) (Table 2). In contrast, any diabetes was associated with DD 
(OR=1.47 [1.07, 2.00]). Adjustment for confounders attenuated the effect estimates in both 
groups (ASD aOR=1.10 [0.77, 1.56]; DD aOR= 1.29 [0.94, 1.78]). Additional adjustment 
for BMI and/or hypertensive disorders further attenuated the effect estimates, but did not 
materially alter the results (Table 2). In subgroup analyses, a stronger association was 
observed with ‘Confirmed’ diabetes, particularly in the DD group. Additionally, while 
stronger associations with ASD and DD were observed for mothers with GDM versus pre-
existing diabetes, estimates were imprecise, with few mothers having pre-existing diabetes.
Hypertensive disorders in pregnancy were associated with both ASD (OR=1.78 [1.35, 2.35]) 
and DD (OR=1.67 [1.28, 2.18]) in unadjusted analyses (Table 2). After adjustment for 
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confounders, effect estimates both remained elevated (ASD aOR=1.69 [1.26, 2.26]; DD 
aOR=1.71 [1.30, 2.25]). Additional adjustment for BMI and diabetes did not notably alter 
effect estimates. In subgroup analyses, stronger associations were observed with 
‘Confirmed’ hypertension. A stronger association was also observed for pre-existing chronic 
hypertension and DD, but not for other sub-classifications of hypertensive disorders.
Associations were generally similar for any diabetes or any hypertensive disorder and ASD 
with ID (vs. POP) compared to ASD without ID (vs. POP) (Table 3), though confidence 
intervals were imprecise due to smaller samples in each sub-group. In one model, however, 
the association with preeclampsia, eclampsia, HELLP syndrome and ASD without ID was 
stronger compared to the ASD with ID group. We did not find any evidence of interaction 
between BMI and diabetes or hypertensive disorders in association with ASD and DD (Table 
4). Sample sizes were insufficient to evaluate the effect through the causal pathway of 
preterm birth. However, associations were attenuated but remained between hypertensive 
disorders and ASD (aOR=1.46 [1.04, 2.04]) or DD (aOR=1.40 [1.01, 1.94)] in children born 
at term (≥37 weeks).
DISCUSSION
We did not observe an association between any diabetes in pregnancy and ASD, but there 
was some suggestion of an association between any diabetes and DD. We observed that any 
hypertensive disorders during pregnancy were associated with ASD in the child. Similar 
associations were also observed between any hypertensive disorders and DD, suggesting a 
more general effect on neurodevelopment rather than specific to ASD processes. Further 
adjustment for BMI and diabetes did not materially alter these associations for hypertensive 
disorders. Overall, stronger associations were seen in mothers with a ‘Confirmed’ condition 
(reported in both the medical record and through maternal report, or in a diagnostic test). 
This may reflect better exposure classification among those with two sources. Confirmed 
conditions may also reflect more severe conditions in pregnancy.
There are several hypotheses regarding how maternal hypertension may affect fetal 
neurodevelopment. Previous studies have established an association between inflammation 
and oxidative stress and hypertensive disorders [Dinh et al., 2014], including those in 
pregnancy [Ferguson et al., 2017]. Oxidative stress and inflammation have also been 
associated with changes in neurodevelopment [Jonakait, 2007; Rose et al., 2012]. Oxidative 
stress may bring about cell necrosis or changes to the epigenome, affecting DNA 
methylation and gene expression [Rose et al., 2012; Main et al., 2013]. Additionally, some 
markers of inflammation are known to cross the blood brain barrier [Jonakait, 2007; Zerbo 
et al., 2013]. Hypertensive disorders are also associated with altered fetal nutrient delivery 
and intrauterine growth restriction [Long et al., 1980]. Changes in nutrient delivery may 
alter fetal metabolism and how the fetus grows and develops in utero, thereby affecting brain 
development.
We observed stronger associations with pre-existing hypertension, specifically with DD. 
This may be related to the timing of the condition during pregnancy and fetal brain 
development, or the association may operate through an alternate pathway involving 
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different metabolic and vascular factors. However, this group may be composed of mothers 
who had a more severe condition throughout pregnancy. Further study with a larger sample 
of mothers with pre-existing chronic hypertension is needed to explore this association. 
Unlike previous studies suggesting etiologically distinct pathways between ASD with and 
without ID [Li et al., 2016], we did not observe differences in the associations for ASD with 
ID versus ASD without ID, with an exception in mothers with preeclampsia, eclampsia, and 
HELLP syndrome.
Previous studies have reported an interaction with high BMI and both maternal diabetes and 
hypertension in association with ASD [Krakowiak et al., 2012; Connolly et al., 2016; Li et 
al., 2016]. Comparing BMI stratum-specific estimates, we did not observe differences in the 
association among mothers with low/normal pre-pregnancy BMI, overweight BMI, or obese 
BMI. Aside from the influence of BMI on development of hypertension, our results suggest 
that BMI may not play a role in the association between maternal hypertension and ASD. 
Sample sizes were insufficient to evaluate the causal pathway through preterm birth, which 
is more common among mothers with hypertensive disorders [Magnussen et al., 2011] and 
among children with ASD [Buchmayer et al., 2009]. However, an association between 
hypertensive disorders and ASD and DD did remain when we restricted the sample to terms 
births only, although it was attenuated. Further investigation on the added effect of preterm 
birth is warranted in a larger sample.
Our results are generally in agreement with other case-control studies that found 
associations between hypertensive disorders and ASD [Buchmayer et al., 2009; Mann et al., 
2010; Walker et al., 2015], but there are subtle differences that may be due to the study 
population and sample size, with SEED having the largest number of affected children over 
multiple sites in the United States. While our results were similar to some studies, they 
differed from others, particularly those reporting a positive association between maternal 
diabetes and ASD [Burstyn et al., 2010; Gregory et al., 2013; Connolly et al., 2016; Li et al., 
2016]. Compared to SEED, most large cohort studies used less detailed data from 
administrative datasets [Burstyn et al., 2010; Connolly et al., 2016] and/or birth certificates 
[Gregory et al., 2013; Connolly et al., 2016], and the somewhat rare exposures limited power 
in smaller studies [Connolly et al., 2016; Li et al., 2016]. Additionally, SEED confirmed 
ASD through a standardized, direct evaluation, instead of relying on ICD-9 codes [Burstyn 
et al., 2010; Connolly et al., 2016; Li et al., 2016] or school records [Gregory et al., 2013] 
that may instead be used to refer the child for further testing and not as a final diagnosis. In 
contrast, all children enrolled in SEED received an in-person evaluation to confirm ASD 
diagnosis with the gold standard instruments, the ADOS and ADI-R. Children in the DD and 
POP group were also screened, reducing outcome misclassification.
The SEED population-based study design is specifically designed to identify etiologic 
factors contributing to ASD. Data regarding risk factors are collected in great detail and 
from multiple sources, including mailed-in questionnaires, telephone interviews, birth 
certificates, and medical records, ensuring that pregnancy conditions are well-captured. For 
this study, we had results from diagnostic tests and clinic and hospital blood pressure 
measurements. These additional data allowed us to include mothers who met diagnostic 
criteria but were missing diagnosis codes in their medical record.
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Although there are many strengths of this study, some limitations exist. Limited data were 
available to characterize the potential for sample selectivity, especially for the POP controls 
sampled from birth records. While a number of families of potentially-eligible children did 
not respond to the SEED invitation letter, analyses of data from one SEED site with the most 
complete data available to assess non-response indicated that maternal age and education 
were associated with participation in the POP group and maternal education was associated 
with participation in the ASD group [Schieve et al., 2018]. However, no differences were 
observed between participants and non-participants for measured pregnancy-related or other 
demographic variables. While we could not fully account for sample selectivity due to 
limited data from non-responders, our analyses adjusted for the aforementioned 
demographic factors known to be associated with participation [Schieve et al., 2018] and we 
have no reason to suspect participation was related to having pregnancy complications 3–5 
years prior to study enrollment.
We aimed to obtain least-biased estimates of the association between maternal conditions 
and child development. We conducted a thorough literature review and used directed acyclic 
graphs to confirm the role of specific variables as confounders, rather than mediators or 
colliders. While our final adjustment set was comparable to or more extensive than previous 
studies, we cannot rule out the possibility that the observed associations resulted from 
residual confounding by an unknown and unmeasured variable, such as a genetic pre-
disposition associated with both the maternal pregnancy condition and child brain 
development.
Diabetes and hypertension are among the most common complications of pregnancy; still 
SEED is one of the few studies with the detailed data necessary to investigate these 
conditions. The level of agreement among the caregiver interview and medical record was 
substantial, however there may be some exposure misclassification due to poor maternal 
recall or incomplete data in the medical record. The availability of medical record data was 
similar for participants in the ASD (69%) and POP (67%) groups, tempering concern about 
the potential for differential misclassification of prenatal health conditions in these groups. 
However, medical record availability was slightly lower for those with DD (62%). Analyses 
that required both caregiver interview and medical record to characterize the condition 
produced effect estimates of greater magnitude. This observation could reflect a better/
confirmed exposure characterization or a more severe condition; while the observed weaker 
associations when maternal report and medical record data were discordant could reflect 
exposure misclassification or a less severe condition. We were unable to fully assess 
heterogeneity in either the severity or timing of maternal hypertension and diabetes during 
pregnancy. Vulnerable periods for fetal brain development are largely unknown and our 
ability to explore critical time windows of exposure to maternal conditions was limited by 
data availability reflecting the presence of these conditions during unique time windows of 
pregnancy and the generally small number of women with these conditions.
In summary, while we did not find an association between maternal diabetes and ASD, we 
did observe an association with maternal hypertensive disorders and both ASD and DD. This 
complements earlier reports among mothers with preeclampsia [Mann et al., 2010; 
Langridge et al., 2013; Walker et al., 2015] and extending them by identifying associations 
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between hypertension diagnosed previous to pregnancy and PIH and both ASD and DD. 
These results contribute to our understanding that maternal conditions during pregnancy and 
altered gestational environment are involved in autism etiology, warranting further 
investigation into the biological mechanism behind associations. Existence of prenatal risk 
factors for ASD may prove to be useful markers to prompt earlier developmental screening.
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Table 1.
Distribution of maternal characteristics during pregnancy with index child born September 2003-August 2006, 
by child outcome classification in SEED (N=2,564)
Maternal Characteristics
Column percent by child outcome
Total Population (N=2,564) ASD (n=698) DD (n=887) POP (n=979)
ASD vs. 
POP p-
value
DD vs. 
POP p-
value
Maternal Age at Conception (mean=31.03, SD= 5.53) 0.3399 0.6185
 < 35 years 1911 (75) 525 (76) 655 (74) 731 (75)
 ≥ 35 years 636 (25) 167 (24) 227 (26) 242 (25)
Maternal Race/Ethnicity <0.0001 <0.0001
 White, non-Hispanic 1614 (63) 288 (56) 541 (61) 685 (70)
 Other 935 (37) 308 (44) 337 (38) 290 (30)
Maternal Education 0.0002 <0.0001
 High school degree or less 372 (15) 113 (16) 160 (18) 99 (10)
 Some college or more 2191 (85) 584 (84) 727 (82) 880 (90)
Maternal Smoking 0.0003 0.0111
 Yes 338 (13) 113 (16) 125 (14) 100 (10)
 No 2206 (86) 578 (83) 757 (85) 871 (89)
Pre-pregnancy Body Mass Index 0.0003 0.0004
 <25 kg/m2 (Low/Normal) 1492 (58) 382 (55) 483 (54) 627 (64)
 25-<30 kg/m2 (High) 603 (24) 171 (25) 221 (25) 211 (22)
 ≥30 kg/m2 (Obese) 419 (16) 132 (19) 158 (18) 129 (13)
Parity 0.7378 0.0093
 First birth 1113 (43) 325 (47) 345 (39) 443 (45)
 Second 908 (35) 231 (33) 327 (37) 350 (36)
 Third or more 510 (20) 129 (18) 204 (23) 177 (18)
Plurality 0.0003 0.0078
 Singleton 9410 (94) 641 (92) 828 (93) 941 (96)
 Multiple 154 (6) 57 (8) 59 (7) 38 (4)
Study Site 0.6116 0.0065
 California 392 (15) 107 (15) 133 (15) 152 (16)
 Colorado 496 (19) 141 (20) 157 (18) 198 (20)
 Georgia 508 (20) 137 (20) 192 (22) 179 (18)
 Maryland 370 (14) 108 (15) 118 (13) 144 (15)
 North Carolina 457 (18) 103 (15) 182 (21) 172 (18)
 Pennsylvania 341 (13) 102 (15) 105 (12) 134 (14)
Diabetes in pregnancy
 No diabetes 2315 (90) 630 (90) 786 (89) 899 (92)
 Any diabetes 246 (10) 68 (10) 100 (11) 78 (8) 0.2091 0.0161
  Confirmed 151 (6) 43 (6) 69 (8) 39 (4) 0.0460 0.0006
  Not confirmed 95 (4) 25 (4) 31 (3) 39 (4) 0.3434 0.6996
  GDM 181 (7) 52 (7) 74 (8) 55 (6) 0.1348 0.0195
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Maternal Characteristics
Column percent by child outcome
Total Population (N=2,564) ASD (n=698) DD (n=887) POP (n=979)
ASD vs. 
POP p-
value
DD vs. 
POP p-
value
  Pre-existing diabetes 65 (3) 16 (2) 26 (3) 23 (2) 0.9822 0.3750
Hypertension in pregnancy
 No hypertensive disorder 2177 (85) 571 (82) 735 (83) 871 (89)
 Any hypertensive disorder 386 (15) 126 (18) 152 (17) 108 (11) <0.0001 0.0001
  Confirmed 195 (8) 68 (10) 76 (9) 51 (5) 0.0002 0.0025
  Not confirmed 191 (7) 58 (8) 76 (9) 57 (6) 0.0409 0.0206
  Pre-existing hypertension 89 (3) 26 (4) 44 (5) 19 (2) 0.0273 0.0005
  PIH 282 (11) 99 (14) 98 (11) 85 (9) 0.0003 0.0633
  Preeclampsia, eclampsia, 
HELLP syndrome 164 (6) 55 (8) 62 (7) 47 (5) 0.0095 0.0493
Autism Res. Author manuscript; available in PMC 2020 June 01.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
Cordero et al. Page 15
Table 2.
Associations between maternal diabetes or hypertensive disorders and ASD or DD in SEED
Model
Exposed n (Column %) ASD vs. POP DD vs. POP
ASD DD POP OR (95%CI) OR (95% CI)
Maternal Diabetes
Diabetes unadjusted 68 (10) 100 (11) 78 (8) 1.24 [0.89, 1.75] 1.47 [1.07, 2.00]
Diabetes adjusteda 65 (10) 96 (11) 78 (8) 1.10 [0.77, 1.56] 1.29 [0.94, 1.78]
Diabetes adjusteda + BMI, HTN 65 (10) 96 (11) 78 (8) 0.96 [0.67, 1.38] 1.16 [0.84, 1.61]
 Confirmed diabetesa 42 (6) 68 (8) 39 (4) 1.45 [0.91, 2.29] 1.80 [1.19, 2.72]
 Pre-existing diabetesa 15 (2) 24 (3) 23 (2) 0.88 [0.45, 1.73] 1.06 [0.59, 1.91]
 GDMa 50 (7) 72 (8) 55 (6) 1.20 [0.80, 1.80] 1.41 [0.97, 2.04]
Maternal Hypertensive Disorders
Hypertension unadjusted 126 (18) 152 (17) 108 (11) 1.78 [1.35, 2.35] 1.67 [1.28, 2.18]
Hypertension adjustedb 123 (18) 150 (17) 106 (11) 1.69 [1.26, 2.26] 1.71 [1.30, 2.25]
Hypertension adjustedb + BMI, DM 123 (18) 150 (17) 106 (11) 1.58 [1.17, 2.13] 1.61 [1.21, 2.14]
 Confirmed hypertensionb 67 (10) 74 (9) 51 (5) 1.84 [1.24, 2.73] 1.79 [1.22, 2.62]
 Pre-existing hypertensionb 26 (4) 44 (5) 19 (2) 1.67 [0.90, 3.11] 2.53 [1.44, 4.42]
 PIHb 96 (14) 96 (11) 84 (9) 1.71 [1.24, 2.37] 1.36 [0.99, 1.87]
 Preeclampsia, eclampsia, and HELLPb 54 (8) 60 (7) 46 (5) 1.69 [1.11, 2.57] 1.56 [1.03, 2.34]
a.Adjusted for maternal age, maternal race/ethnicity, maternal education, maternal smoking, and study site.
b.Adjusted for above (a.) plus plurality and parity.
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Table 3.
Associations between maternal diabetes or hypertensive disorders and ASD with (n=258) and without (n=429) 
intellectual disabilities (ID) in SEED
Model
Exposed n (Column %) ASD with ID
vs. POP
aOR (95% CI)
ASD without ID
vs. POP
aOR (95% CI)ASD with ID ASD without ID POP
Maternal Diabetes
Diabetesa  44 (10) 21 (8)  78 (8) 1.23 [0.82, 1.85] 0.98 [0.59, 1.63]
 Pre-existing diabetesa 10 (2) 5 (2) 23 (2) 0.92 [0.42, 2.03] 0.83 [0.31, 2.22]
 GDMa 34 (8) 16 (6) 55 (6) 1.37 [0.87, 2.17] 1.05 [0.58, 1.87]
Maternal Hypertensive Disorders
Hypertensionb 74 (18) 45 (18) 106 (11) 1.68 [1.20, 2.37] 1.64 [1.11, 2.42]
 Pre-existing hypertensionb 18 (4) 7 (3) 19 (2) 1.72 [0.86, 3.45] 1.52 [0.63, 3.70]
 PIHb 56 (13) 37 (15) 84 (9) 1.73 [1.18, 2.52] 1.67 [1.09, 2.55]
 Preeclampsia, eclampsia, HELLPb 27 (7) 24 (10) 46 (5) 1.37 [0.81, 2.29] 1.90 [1.12, 3.21]
a.Adjusted for maternal age, race/ethnicity, maternal education, maternal smoking, and study site.
b.Adjusted for above (a.) plus plurality and parity.
Autism Res. Author manuscript; available in PMC 2020 June 01.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
Cordero et al. Page 17
Table 4.
Stratum-specific effect estimates for maternal diabetes and hypertensive disorders for three strata of maternal 
pre-pregnancy BMI in SEED
Model / Strata
ASD vs. POP aOR 
(95% CI)
p-value for interaction DD vs. POP aOR 
(95% CI)
p-value for interaction
Maternal Diabetes
BMI: low, normal (<25 kg/m2)a 0.95 [0.71, 1.27] Reference 1.23 [0.97, 1.57] Reference
BMI: overweight (25-<30 kg/m2)a 0.99 [0.71, 1.37] 0.874 0.94 [0.69, 1.28] 0.1833
BMI: obese (≥30 kg/m2)a 1.10 [0.80, 1.52] 0.523 1.08 [0.79, 1.57] 0.522
Maternal Hypertensive Disorders
BMI: low, normal (<25 kg/m2) b 1.33 [1.06, 1.67] Reference 1.36 [1.10, 1.68] Reference
BMI: overweight (25-<30 kg/m2)b 1.23 [0.93, 1.64] 0.687 1.31 [1.00, 1.72] 0.840
BMI: obese (≥30 kg/m2)b 1.17 [0.89, 1.53] 0.479 1.12 [0.86, 1.46] 0.263
a.Adjusted for maternal age, race/ethnicity, maternal education, maternal smoking, and study site.
b.Adjusted for above (a.) plus plurality and parity.
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